Eng

Singaporean fintech firm GoBear lays off staff due to COVID-19 crisis

KrASIA
更新於 2020年09月01日18:07 • 發布於 2020年09月01日10:07 • Khamila Mulia

Singapore-headquartered fintech firm GoBear announced Tuesday it had laid off 22 staff from offices in Singapore, Vietnam, Philippines, and Ukraine as a result of the ongoing impact of the COVID-19 crisis, representing 11% of its total workforce. Those affected were spread across operations, product, and tech teams.

In an internal memo, CEO Adrian Chng said the company is focused on reducing non-people costs first, with layoffs taken as a last resort. GoBear has reviewed and implemented a number of cost-cutting measures before making this decision, he said, including halting non-essential projects, and reducing fixed costs and software licenses.

“Like many businesses, the repercussions from the current global COVID-19 situation have meant that we have had to take measures to adapt our business to overcome challenges and future-proof it for what lies ahead, by focusing on our growth engines of digital lending and digital insurance brokerage,” Chng said in an official statement. “We are providing full post-employment support to those affected and I want to personally thank them for their contribution to building the business that GoBear is today.”

廣告(請繼續閱讀本文)

The firm also said it is providing outgoing employees with support such as severance packages according to local laws and regulations.

GoBear started the year with USD 17 million of new funding in May. In early August, the company also teamed up with Phillipines’ UnionBank to launch a Lending-as-a-Service (LaaS) partnership in that country.

However, the pandemic has dampened the company’s good fortune along with others in Singapore. In June, Grab announced a region-wide layoff of about 5% of its employees. Not long after, its competitor Gojek followed suit by letting go of 430 employees, or roughly 9% of its total staff.

廣告(請繼續閱讀本文)
查看原始文章

更多 Eng 相關文章

Xinhua Commentary: Chinese economy progressing well in pursuit of 2024 targets
XINHUA
LG Innotek Shines on Global Stage with Automotive Lighting Innovations
PR Newswire (美通社)
Drones relay to complete power network inspections
XINHUA
Xinhua News | Arab League condemns U.S. veto on UN resolution demanding Gaza ceasefire
XINHUA
Tourism revenue hits new high at Horgos port in Xinjiang
XINHUA
BingX Launches Spot Innovation Zone to Capture Opportunities in Bullish Markets
PR Newswire (美通社)
FedEx boosts Xiamen-U.S. cargo flight services
XINHUA
Sungrow Strengthens Australian Market Presence with 1.7GWh of C&I Energy Storage Partnerships with Raystech and Solar Juice
PR Newswire (美通社)
Proposed U.S. tariffs risk fueling inflation, slowing economic growth: economists
XINHUA
HKFDA’s Virtuose puts Hong Kong at the forefront of fashion through a stunning couture showcase
Tatler Hong Kong
CCTV+: Embarking on a Renewed Dialogue at Liangzhu Between Global Civilizations--The 'Liangzhu: A Dialogue across World Civilizations' Promotional Video and Documentary to Premier
PR Newswire (美通社)
Hanwha Power Systems signs MOU with TC Energy to accelerate commercialization of sCO2 power generation
PR Newswire (美通社)
Global Times: Neo-Chinese cuisine: How China is reimagining its food heritage
PR Newswire (美通社)
Cambodia targets 70 pct clean energy by 2030: minister
XINHUA
Turfan's Real-Time Power Response System Boosts Regional Tourism
PR Newswire (美通社)
The Global AI Defense Challenge 2024 Announces Winners Across Two Competition Tracks
PR Newswire (美通社)
Two In Vitro Studies on Eravacycline (XERAVA®) Presented at IDWeek, Demonstrating Its Sustained and Robust Antimicrobial Activity
PR Newswire (美通社)
Foreign guests experience vitality of urban development in China's "Spring City"
XINHUA
Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology
PR Newswire (美通社)
Update: China has half of top 20 science cities: Nature Index
XINHUA
APRIL Group Supports National Health Development in Riau Province, Indonesia
PR Newswire (美通社)
Deep Dive into Today's Clothing Shoppers
PR Newswire (美通社)
Olverembatinib Surmounts Ponatinib and Asciminib Resistance and Is Well Tolerated in Patients With CML and Ph+ ALL: New Report in JAMA Oncology
PR Newswire (美通社)
Xinjiang reaps pearl harvest through pioneering inland aquaculture
XINHUA